103 related articles for article (PubMed ID: 30899398)
1. Arsenic trioxide inhibits Skp2 expression to increase chemosensitivity to gemcitabine in pancreatic cancer cells.
Gao J; Wang G; Wu J; Zuo Y; Zhang J; Chen J
Am J Transl Res; 2019; 11(2):991-997. PubMed ID: 30899398
[TBL] [Abstract][Full Text] [Related]
2. Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells.
Gao J; Wang G; Wu J; Zuo Y; Zhang J; Jin X
Mol Ther Oncolytics; 2019 Mar; 12():214-223. PubMed ID: 30847385
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide-loaded nanoparticles enhance the chemosensitivity of gemcitabine in pancreatic cancer
Zhao Y; Yao H; Yang K; Han S; Chen S; Li Y; Chen S; Huang K; Lian G; Li J
Biomater Sci; 2022 Oct; 10(20):5989-6002. PubMed ID: 36052559
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells.
Gao JK; Wang LX; Long B; Ye XT; Su JN; Yin XY; Zhou XX; Wang ZW
Asian Pac J Cancer Prev; 2015; 16(9):3805-10. PubMed ID: 25987041
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells.
Su J; Zhou X; Wang L; Yin X; Wang Z
Am J Cancer Res; 2016; 6(9):1949-1962. PubMed ID: 27725901
[TBL] [Abstract][Full Text] [Related]
6. A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer.
Byun WS; Jin M; Yu J; Kim WK; Song J; Chung HJ; Jeong LS; Lee SK
Biochem Pharmacol; 2018 Dec; 158():84-94. PubMed ID: 30292755
[TBL] [Abstract][Full Text] [Related]
7. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
8. AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transition.
Wang X; Song Z; Chen F; Yang X; Wu B; Xie S; Zheng X; Cai Y; Chen W; Zhong Z
Am J Transl Res; 2018; 10(12):4095-4106. PubMed ID: 30662653
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells
Yang X; Wang W; Zhang X; Zou Q; Cai L; Yu B
Exp Ther Med; 2019 Mar; 17(3):1697-1705. PubMed ID: 30783438
[TBL] [Abstract][Full Text] [Related]
10. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
11. Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy.
Wang S; Feng W; Wang W; Ye X; Chen H; Yu C
Front Oncol; 2021; 11():618764. PubMed ID: 33854963
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli.
Han JB; Sang F; Chang JJ; Hua YQ; Shi WD; Tang LH; Liu LM
Onco Targets Ther; 2013; 6():1129-38. PubMed ID: 23990729
[TBL] [Abstract][Full Text] [Related]
13. E2F1 downregulation by arsenic trioxide in lung adenocarcinoma.
Lam SK; Li YY; Zheng CY; Leung LL; Ho JC
Int J Oncol; 2014 Nov; 45(5):2033-43. PubMed ID: 25174355
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944.
Gao G; Li X; Wu H; Huang LL; Lin YX; Huo Z; Xiang ZY; Zhou X
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259332
[TBL] [Abstract][Full Text] [Related]
15. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.
Wang W; Zhou X; Kong L; Pan Z; Chen G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672622
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells.
Su J; Wang L; Yin X; Zhao Z; Hou Y; Ye X; Zhou X; Wang Z
Am J Cancer Res; 2016; 6(10):2178-2191. PubMed ID: 27822410
[TBL] [Abstract][Full Text] [Related]
17. Albumin conjugation promotes arsenic trioxide transport through alkaline phosphatase-associated transcytosis in MUC4 wildtype pancreatic cancer cells.
Chen K; Cheng X; Xue S; Chen J; Zhang X; Qi Y; Chen R; Zhang Y; Wang H; Li W; Cheng G; Huang Y; Xiong Y; Chen L; Mu C; Gu M
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128756. PubMed ID: 38092098
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Molecular Therapeutic Mechanisms of Gemcitabine through Quantitative Proteomics.
Jiang Y; Ren X; Zhao J; Liu G; Liu F; Guo X; Hao M; Liu H; Liu K; Huang H
J Proteome Res; 2024 Jun; ():. PubMed ID: 38831540
[TBL] [Abstract][Full Text] [Related]
19. 4-Acetylantroquinonol B enhances cell death and inhibits autophagy by downregulating the PI3K/Akt/MDR1 pathway in gemcitabine-resistant pancreatic cancer cells.
Chen YY; Chen SY; Li TJ; Lin TW; Chen CC; Yen GC
Oncol Lett; 2022 Apr; 23(4):128. PubMed ID: 35251348
[TBL] [Abstract][Full Text] [Related]
20. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
